Search

Spring 2015

Harwood, Lori E

Abstract People with Chronic Kidney Disease (CKD) are asked to make important decisions about if, where and how they will receive dialysis. As the population in Canada ages with increased co-morbidity such as diabetes and hypertension, the need for high cost treatments for CKD such as dialysis...

Fall 2023

Li, Shuhui

The removal of uremic toxins is of great importance in preventing the progression of chronic kidney disease. The investigation of the interaction of uremic toxins with serum and dialysis materials will contribute to the advancement of techniques in uremic toxins removal. This study investigates...

Spring 2022

Puri, Alisha

Background: Frailty is three to seven times more common in people with chronic kidney disease (CKD) than in those with normal kidney function. Although frailty and its impact in CKD is well-recognized, the measurement properties of the tools used to assess this syndrome are not known. The aim of...

Fall 2017

McAllister, Jayson C. W.

Chronic Kidney Disease (CKD) affects millions of people throughout the world today. One of the major side effects of this disease is the inability to regulate the body’s red blood cell production, and subsequently the mass of the protein called hemoglobin within the body. The health of these...

Fall 2024

Pawar, Aishwarya Shrikrishna

Protein adsorption to implanted biomaterials can direct host responses and lead to health complications and device failure. Polyethylene oxide (PEO) is the gold standard film for reducing non-specific protein adsorption. Although polymer chain density is an important factor in determining PEO’s...

Fall 2013

Schwindt, Stephanie T

Vitamin D (vitD) is a nutrient of concern in Canada particularly for those with diabetes and chronic kidney disease (CKD). Participants (18-80y) with diabetes and CKD were randomized to receive either 50mcg/day (n=33) or 1,000mcg/month (n=30) vitD3 for 6-months. Variables studied included:...